Last reviewed 2026-04-20 · How we verify

pandemic vaccine 5

At a glance

Approved indications

No approved indications tracked.

Common side effects

• Injection site pain
• Fatigue
• Myalgia
• Headache
• Pain
• Injection site swelling
• Injection site erythema
• Induration
• Arthralgia
• Pyrexia
• Muscle aches
• Hyperhidrosis

Key clinical trials

• A Phase I/II Study on Safety AND Immunogenicity of AZD4117 and AZD5315 Vaccines (PANDA) (PHASE1, PHASE2)
• A Study to Learn How Safe, Tolerable and Capable of Producing an Immune Response is, a Modified RNA Vaccine Against Pandemic Influenza (PHASE1)
• A Study to Find and Confirm the Dose and Assess Safety, Reactogenicity and Immune Response of a Vaccine Against Pandemic H5N1 Influenza Virus in Healthy Younger and Older Adults (PHASE1, PHASE2)
• Establishing a Controlled Human Infection Model for Influenza H3N2 as a Foundation for Pandemic Preparedness (PHASE1)
• Impact and Effectiveness of ABRYSVO® Vaccination During Pregnancy
• Safety and Immunogenicity Study of Adenovirus-vectored, Intranasal Pandemic Influenza Vaccine. (PHASE1)
• Safety and Immunogenicity Study of a Booster Dose of the Investigational CV0501 mRNA COVID-19 Vaccine in Adults at Least 18 Years Old (PHASE1)
• Safety, Reactogenicity, and Immunogenicity Trial of CV2CoV mRNA Vaccine Against SARS-CoV-2 in Seropositive Adult Participants (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

• pandemic vaccine 5 CI brief — competitive landscape report
• pandemic vaccine 5 updates RSS · CI watch RSS
• Butantan Institute portfolio CI